Prostacyclin and thromboxane in ovarian cancer: Effect of cytostatics and prostaglandin synthesis inhibitors
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 16 (3) , 340-345
- https://doi.org/10.1016/0090-8258(83)90160-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Prostacyclin and thromboxane in diabetes.BMJ, 1981
- The role of prostaglandins in the excessive nausea and vomiting after intravascular cis-platinum therapyGynecologic Oncology, 1981
- Prostacyclin: A Potent Antimetastatic AgentScience, 1981
- Idiosyncratic platelet responses to human tumour cellsNature, 1981
- Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesisCancer Treatment Reviews, 1979
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant diseaseInternational Journal of Cancer, 1973